The results of EUROASPIRE I, II and III surveys demonstrated a high prevalence of unhealthy lifestyles, modifiable risk factors and inadequate use of drug therapies to achieve blood pressure and lipid goals in patients with established CHD and people at high risk of developing cardiovascular disease. There were wide variations in medical practice between countries in the treatment of these patients.
A fourth EUROASPIRE survey of Cardiovascular Disease Prevention and Diabetes is now proposed, which will merge with the EuroHeart Survey on Diabetes Mellitus and incorporate an assessment of dysglycaemia (impaired fasting glycaemia IFG, impaired glucose tolerance IGT and new diabetes) in all patients.
To give a unique European picture of prevention action by cardiologists, other specialists and primary care physicians looking after patients with coronary disease.
As in the previous EUROASPIRE surveys, this survey focuses on:
There are numerous publications to read following the EUROASPIRE registry results over the years (I, II, III and IV) and there will be more to come.
The Scientific Steering Committee, chaired by Doctor Kornelia Kotseva, is composed of the Executive Committee, the National Coordinators of participating countries and with Professor David Wood as Principal Investigator of the registry.
The Executive Committee of the survey is chaired by Professor Guy De Backer.
Guy De Backer, BEKornelia Kotseva, UKDavid Wood, UKDirk De Bacquer, BELars Rydén, SEStephan Gielen, DEOliver Schnell, DEJouko Sundvall, FIJaakko Tuomilehto, FIPhilippe Amouyel, FRAldo P. Maggioni, EORP Scientific coordinator (ex officio), IT
Our mission: To reduce the burden of cardiovascular disease
© 2018 European Society of Cardiology. All rights reserved